Compositions and methods for the treatment of inflammation and pain

Patent metadata

Field	Value
Publication number	US-10227301-B2
Application number	US-201514647130-A
Country	US
Kind code	B2
Filing date	May 7, 2015
Priority date	Jan 6, 2015
Publication date	Mar 12, 2019
Grant date	Mar 12, 2019

Abstract

The invention relates to the compounds of formula I, formula II, formula III, formula IV and formula V or its pharmaceutical acceptable polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, formula II, formula III, formula IV or formula V and methods for the treatment of inflammation and pain may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, oral solution, buccal mucosal layer tablet, parenteral administration, syrup, or injection. Such compositions may be used to treatment of pain, oral mucosal inflammatory or oral infectious diseases.

First claim

I claim:

1. A compound of Formula V:

and pharmaceutically acceptable hydrates, solvates, enantiomers, and stereoisomers thereof, wherein RH independently represents
1-hydroxy-2-naphthoic acid, 2,2-dichloroacetic acid, 2-oxoglutaric acid, 4-acetamidobenzoic acid, adipic acid, capric acid, caproic acid, cyclamic acid, galactaric acid, gentisic acid, glucoheptonic acid, gluconic acid, glucuronic acid, glutamic acid, glutaric acid, glycolic acid, hippuric acid, isobutyric acid, lactic acid, lactobionic acid, lauric acid, malonic acid, mandelic acid, pamoic acid, proprionic acid, pyroglutamic acid, salicylic acid, sebacic acid, stearic acid, thiocyanic acid, toluenesulfonic acid, undecylenic acid, n-acetyl cysteine (nac), furoate, methyl furoate, ethyl furoate, aminocaproic acid, caprilic acid, myristic acid, myristoleic acid, palmitic acid, palmitoleic acid, oleic acid, elaidic acid, linolelaidic acid or arachidonic acid.

2. A pharmaceutical composition comprising a compound of claim 1 and a pharmaceutically acceptable carrier.

3. The pharmaceutical composition of claim 2 , wherein said pharmaceutical composition is formulated to treat inflammation mediated pain in a patient in need thereof with an effective amount of said pharmaceutical composition, and wherein said pharmaceutical composition is administered to the patient in need by oral administration, delayed release or sustained release, transmucosal administration, syrup, mucoadhesive, buccal formulation, mucoadhesive tablet, topical administration, parenteral administration, injection, subdermal administration, oral solution, rectal administration, buccal administration or transdermal administration.

4. The pharmaceutical composition of claim 3 , wherein said inflammation mediated pain is caused by oral mucositis, oral ulceration, oral inflammation, oral infection, oral wounds, dental surgery, post-tonsillectomy, odontostomatology, gingivitis, stomatitis, glossitis, aphthous ulcers, pharyngitis, tonsillitis, radiation or intubation mucositis.

5. A method of treating mucositis or pain, wherein the method comprises administering to a patient in need thereof a therapeutically effective amount of the pharmaceutical composition of claim 2 , and wherein said pharmaceutical composition is administered to the patient in need by oral administration, delayed release or sustained release, transmucosal administration, syrup, lozenge, spray, mucoadhesive, buccal formulation, mucoadhesive tablet, topical administration, parenteral administration, injection, subdermal administration, oral solution, rectal administration, buccal administration or transdermal administration.

6. A method of treating pain of claim 5 , wherein the pain is associated with mucositis, dental surgery, oral ulceration, post-tonsillectomy, odontostomatology, gingivitis, stomatitis, glossitis, aphthous ulcers, oral ulceration, pharyngitis, tonsillitis, radiation or intubation mucositis.

Assignees

• Cellix Bio Private Ltd

Inventors

• Kandula Mahesh

Classifications

• A61P29/00

  Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title

• C07D211/60 Primary

  Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title

• C07C57/12

  Straight chain carboxylic acids containing eighteen carbon atoms · CPC title

• C07C65/11

  with carboxyl groups on a condensed ring system containing two rings · CPC title

• C07C53/126

  Acids containing more than four carbon atoms · CPC title